Angela Lamarca/X
Dec 7, 2024, 14:35
Angela Lamarca: Update from HIMALAYA trial in HCC
Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post on X:
“Update from HIMALAYA trial in HCC.
Benefit is the same regardless of ALBI score.
No more toxicity in ALBI2.”
More posts featuring Angela Lamarca.
Angela Lamarca, MD, PhD, MSc, is a Consultant in Medical Oncology at Jiménez Díaz Foundation University Hospital and The Christie NHS Foundation Trust. She also serves as an Honorary Consultant in Medical Oncology and Honorary Senior Lecturer at The University of Manchester.
Dr. Lamarca specializes in gastrointestinal malignancies, particularly hepato-pancreato-biliary (HPB) cancers and neuroendocrine tumors (NETs).
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 18, 2025, 20:22
Apr 18, 2025, 20:12
Apr 18, 2025, 20:03
Apr 18, 2025, 19:54
Apr 18, 2025, 19:49
Apr 18, 2025, 19:44
Apr 18, 2025, 19:26